Which of the following antiplatelet agents exerts its effect through a mechanism that is independent of cell surface receptor antagonism and is functionally irreversible for the lifespan of the platelet?

A 78-year-old male with a history of chronic pancreatitis and end-stage renal disease (ESRD) on hemodialysis is brought to the emergency department for altered mental status and sudden, brief, jerky movements of his limbs. On examination, his respiratory rate is 10 breaths/min, pupils are 3 mm and reactive, and he exhibits multifocal myoclonus. He was recently prescribed an opioid for a severe pain episode. Which of the following is the most likely causative agent?

Which of the following pharmacological agents exhibits a ceiling effect on respiratory depression due to its unique interaction with the µ-opioid receptor, making it a safer option in certain patient populations for opioid use disorder?

A 22-year-old female college student is diagnosed with Major Depressive Disorder (MDD) co-morbid with Bulimia Nervosa. She expresses significant concern about medication-induced weight gain, as it is a major trigger for her eating disorder behaviours. Which of the following SSRIs would be the most appropriate first-line agent for this patient?

A 72-year-old male with a history of benign prostatic hyperplasia (BPH) and narrow-angle glaucoma is diagnosed with major depressive disorder accompanied by significant fatigue and poor concentration. Given his comorbidities, which of the following medications offers a therapeutic advantage primarily by avoiding antagonism of histaminic, cholinergic, and alpha-adrenergic receptors?

The central anticholinergic toxidrome (e.g., delirium, mydriasis) caused by a tricyclic antidepressant overdose is specifically antagonized by the administration of which of the following agents?

A 54-year-old male with a history of bipolar I disorder, well-managed on lithium for the past 8 years, presents to the emergency department with complaints of persistent diarrhea, a fine tremor in his hands, and tinnitus. His wife reports he has been increasingly unsteady on his feet (ataxia) over the last week. His serum lithium level is 1.9 mEq/L. Which of the following recent changes is the most likely precipitant of his current condition?

A 28-year-old female, maintained on lithium for cyclothymic disorder, is attending a preconception counseling appointment. When discussing the potential teratogenic risks associated with in-utero lithium exposure, which specific cardiac malformation should be highlighted as the most characteristic risk?

A 34-year-old male with treatment-resistant schizophrenia, previously unresponsive to adequate trials of risperidone and olanzapine, was initiated on clozapine five weeks ago. He presents to the emergency department with a fever of 38.4°C, pleuritic chest pain, and dyspnea. His heart rate is 120 bpm and regular. A complete blood count and differential are within normal limits. Which of the following is the most critical immediate investigation?

Among the atypical antipsychotics, which agent uniquely combines a mechanism of D2 receptor partial agonism with one of the lowest risks for inducing significant weight gain and metabolic dysregulation?

A 68-year-old male with a 20-year history of schizophrenia, managed with long-term fluphenazine decanoate injections, is brought in by his caregiver for evaluation of new, involuntary, rhythmic perioral movements resembling chewing, which persist during sleep. His vital signs are stable, and a physical exam is otherwise unremarkable. Which pharmacological agent is the most appropriate next step?

A 34-year-old male with chronic schizophrenia, previously managed on haloperidol, is switched to a new agent due to persistent negative symptoms. Six months later, his BMI has increased from 25 to 31 kg/m ², and his HbA1c is 6.8%. His negative and positive symptoms, however, are significantly improved. Which medication, known for its potent 5-HT2C and H1 antagonism, is the most likely cause of these metabolic changes?

A 42-year-old female with a history of bipolar I disorder presents for medication management. She is concerned about significant weight gain experienced with previous mood stabilizers. Her current BMI is 32 kg/m ². Which of the following agents offers a therapeutic advantage by addressing both her psychiatric condition and her metabolic concern?

A 45-year-old male with a history of generalized tonic-clonic seizures, chronic migraines, and a BMI of 32 kg/m ² presents for follow-up. He also has a history of alcohol use disorder and expresses a strong desire to maintain abstinence. Which single agent would be the most comprehensive choice to address his multiple comorbidities?

A 28-year-old female with a history of bipolar I disorder, managed with valproate for the past three years, presents to the emergency department with acute-onset, severe epigastric pain radiating to her back. She also reports nausea and anorexia. On examination, she is afebrile, tachycardic, and has marked tenderness in the upper abdomen. Laboratory investigations reveal significantly elevated serum amylase and lipase levels. What is the most likely diagnosis?

A 7-year-old girl presents with daily episodes of behavioral arrest and eyelid fluttering lasting 15 seconds. Her parents also report occasional morning episodes of abrupt, bilateral arm jerking. An EEG demonstrates generalized 3 Hz spike-and-wave discharges. What is the most appropriate initial monotherapy?

A 32-year-old G1P0 at 34 weeks gestation with a blood pressure of 180/110 mmHg experiences a generalized tonic-clonic seizure. The first-line agent is administered intravenously. Its primary anticonvulsant effect is mediated through which mechanism?

Which of the following NMDA receptor antagonists is therapeutically co-formulated with a cytochrome P450 2D6 (CYP2D6) inhibitor to increase its plasma concentration and efficacy for the treatment of pseudobulbar affect?

A 16-year-old female with a known history of juvenile myoclonic epilepsy (JME) is managed on monotherapy. Her generalized tonic-clonic seizures are well-controlled, but she continues to have several daily episodes of brief staring spells, confirmed as absence seizures on EEG. Which of the following mechanisms of her current medication is primarily responsible for targeting these absence seizures?